Home > Search Clinical Trials > 25-363-2
Clinical Trials: 25-363-2
IRB No. 25-363-2 (Dr. Prazwala Chirravur, PI): The Effect of Dietary Xylooligosaccharides (XOS) on the Composition of the Human Oral Microbiome
SPECIFIC AIM: To assess the modulatory effect of dietary xylooligosaccharides (XOS) on the composition of the human oral microbiome .